Sony

The test is Micronics’ first to receive FDA clearance, and the company is pursuing CE marking for it and the PanNAT system.

Korea Institute of Science and Technology has been awarded

Applied Biosystems (Life Technologies) has been awarded US Patent No. 8,637,658, "Non-fluorescent quencher compounds and biomolecular assays."

NEW YORK (GenomeWeb News) – Sony Corporation and M3 plan to establish a new company in Japan by the end of February 2014 in which Illumina will be a minority investor. Additionally, the three firms will collaborate to launch a new genome information platform in Japan, the firms said today.

Bio-Rad has been awarded US Patent No. 8,633,015, "Flow-based thermocycling system with thermoelectric cooler."

Sony of Tokyo has received US Patent No.

Micronics (Sony) has been awarded US Patent No. 8,431,389, "Portable high-gain fluorescence detection system."
Frederick Battrell and Troy Daiber are named as inventors.

Saint Louis University has received US Patent No. 8,431,388, "Three-component biosensors for detecting macromolecules and other analytes." According to the patent, the molecular biosensor generally consists of two epitope-binding agents and an oligonucleotide construct.

Roche Molecular Systems has been awarded US Patent No. 8,329,884, "Reagents and methods for detecting Neisseria gonorrhoeae."
Diane Kawa, Shi-Da Lu, and Peter Dailey are named as inventors.

Aushon Biosystems of Billerica, Mass., has received US Patent No. 8,246,760, "Continual flow pin washer." The patent describes a multi-chambered deposition pin wash station that includes a lower chamber and an upper drain basin connected by wash tubes.

Pages

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.